Jefferies has upgraded Safran Group's stock rating to "buy" from "hold," citing robust growth prospects and appealing opportunities for long-term investors. The decision follows Safran’s Capital Markets Day, where the company outlined ambitious plans for earnings growth and strategic investments.
Analysts project Safran’s earnings per share to achieve a 21% compounded annual growth rate from 2023 to 2028. Key drivers include strong aftermarket trends in civil aerospace and the LEAP engine program's profitability, expected from 2025. Additional tailwinds include favorable foreign exchange rates and a €5 billion share buyback plan aimed at enhancing shareholder returns.
Jefferies raised its price target for Safran to €260, reflecting an 18% upside from current levels. Analysts highlight the stock's undervaluation compared to European aerospace peers, presenting an attractive entry point into this growth story.
Free cash flow projections have also been revised upward, with 2025 expected to hit the high end of Safran’s guidance. This optimism stems from anticipated down payments tied to a significant Indian Navy Rafale jet order.
Jefferies notes concerns over cash flow have eased, and Safran is well-prepared to manage supply chain and inflationary pressures. Additionally, conservative assumptions in Safran’s 2028 guidance, such as shop visits for the CFM56 engine fleet, suggest potential upside beyond current forecasts.
Despite minor challenges, Jefferies believes Safran’s operational resilience and strategic initiatives solidify its position as a compelling investment in the aerospace sector.


Markets Steady as Fed Signals Caution on Rate Cuts
Global Currency Shifts After BOJ Rate Hike and Trump's Tariff Comments
Gold Soars to One-Month High as Weak Jobs Data Fuels Fed Rate Cut Speculation
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal
Microsoft Stock Upgraded as Stifel Sees Stronger Azure Growth
White House Bars CNN, MS NOW and Politico Reporters
Telix to Acquire Germany’s ITM in $1.65 Billion Radiopharma Deal
CNN, MS NOW and Politico Sue Trump Over White House Media Ban
S&P 500 Rises Amid Cyclical Stock Gains, Inflation Data Looms
Anthropic’s Claude Discovers CRISPR-Like Enzyme System
S&P 500 Relies on Tech for Growth in Q4 2024, Says Barclays
Gold Prices Set to Hit New Highs in 2025 Amid Market Volatility
Volkswagen Shares Slide After 2026 Profit Outlook Cut
Asian Markets React to Tariff Reports and Fed Policy Shifts
Westinghouse Targets $50 Billion Valuation in U.S. IPO
U.S. Stocks Hit Unprecedented Peaks Amid Growing Speculation of Federal Rate Cuts
IMF Warns Japan of Market Volatility and Interest Rate Risks 



